IPAD-DB ID | D01388 |
Name | PNU282987 |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 4 H 1 7 C l N 2 O |
Molecular Weight | 264.75 g/mol |
IUPAC Name | N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-4-chlorobenzamide |
InChI | InChI=1S/C14H17ClN2O/c15-12-3-1-11(2-4-12)14(18)16-13-9-17-7-5-10(13)6-8-17/h1-4,10,13H,5-9H2,(H,16,18)/t13-/m0/s1 |
InChIKey | WECKJONDRAUFDD-ZDUSSCGKSA-N |
Canonical SMILES | C1CN2CCC1C(C2)NC(=O)C3=CC=C(C=C3)Cl |
PubChem CID | 9795278 |
DrugBank Accession Number | - |
CAS Registry Number | 711085-63-1 |
Molecular Weight(Computed by SwissADME) | 264.75 |
Hac(Computed by SwissADME) | 18 |
Volume(Computed by ADMETlab 2.0) | 260.48 |
Density(Computed by ADMETlab 2.0) | 1.014 |
nRing(Computed by ADMETlab 2.0) | 4 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 16 |
Flexibility(Computed by ADMETlab 2.0) | 0.188 |
Stero Centers(Computed by ADMETlab 2.0) | 1 |
LogS(Computed by ADMETlab 2.0) | -2.825 |
LogD(Computed by ADMETlab 2.0) | 2.321 |
logP(Computed by ADMETlab 2.0) | 2.544 |
TPSA(Computed by SwissADME) | 32.34 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 3 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.18 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |